Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression

BACKGROUND: Psychotic depression has no Food and Drug Administration–approved treatment. Patients demonstrate significant dysregulation of the hypothalamic-pituitary-adrenal axis providing a biologically targeted treatment opportunity. The purpose of this study was to explore the clinical and biolog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychopharmacol
Autors principals: Block, Thaddeus, Petrides, Georgios, Kushner, Harvey, Kalin, Ned, Belanoff, Joseph, Schatzberg, Alan
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2017
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596828/
https://ncbi.nlm.nih.gov/pubmed/28708736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000744
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars